Ergocalciferol and Prolensa drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Ergocalciferol (ergocalciferol) and Prolensa (bromfenac sodium). Common drug interactions include hypertension among females and chronic kidney disease among males.
The phase IV clinical study analyzes what interactions people have when they take Ergocalciferol and Prolensa. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Ergocalciferol?
Ergocalciferol has active ingredients of ergocalciferol. It is often used in rickets. eHealthMe is studying from 32,652 Ergocalciferol users. Check the latest studies of Ergocalciferol.
What is Prolensa?
Prolensa has active ingredients of bromfenac sodium. eHealthMe is studying from 1,170 Prolensa users. Check the latest studies of Prolensa.
12 people who take Ergocalciferol and Prolensa together, and have interactions are studied.

What are the common drug interactions of Ergocalciferol and Prolensa, by gender? *:
female:
- Hypertension (high blood pressure)
- Neuralgia (pain in one or more nerves)
- Oedema (fluid collection in tissue)
- Hospitalisation
- Abnormal dreams
- Asthenia (weakness)
- Burning sensation
- Cataract (clouding of the lens inside the eye)
- Constipation
- Deafness
male:
- Chronic kidney disease
- Nephropathy (damage to or disease of a kidney)
- Constipation
- Diarrhoea
- Dizziness
- Oral pruritus (itching in mouth)
- Vomiting
- Weight decreased
What are the common drug interactions of Ergocalciferol and Prolensa, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
- Abnormal dreams
- Asthenia (weakness)
- Diarrhoea
- Disturbance in attention
- Dizziness
- Headache (pain in head)
- Infrequent bowel movements
- Nausea (feeling of having an urge to vomit)
- Restlessness (not able to rest)
- Somnolence (a state of near-sleep, a strong desire for sleep)
50-59:
- Diarrhoea
- Vomiting
- Weight decreased
60+:
- Depression
- Hypertension (high blood pressure)
- Suicide attempt
- Neuralgia (pain in one or more nerves)
- Oedema (fluid collection in tissue)
- Chronic kidney disease
- Nephropathy (damage to or disease of a kidney)
- Constipation
- Dizziness
- Oral pruritus (itching in mouth)
What are the existing conditions these people have? *
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 6 people, 50.00%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 41.67%
- Stress And Anxiety: 1 person, 8.33%
- Herpes Zoster: 1 person, 8.33%
- Blood Pressure Abnormal: 1 person, 8.33%
- Calcium Deficiency (lack of calcium): 1 person, 8.33%
- Central Nervous System Stimulation: 1 person, 8.33%
- Chronic Kidney Disease: 1 person, 8.33%
- Depression: 1 person, 8.33%
- Diabetes: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Ergocalciferol and Prolensa?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Ergocalciferol (32,652 reports)
- Prolensa (1,170 reports)
Browse all drug interactions of Ergocalciferol and Prolensa:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ergocalciferol:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Prolensa:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ergocalciferol and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Prolensa and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
- Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
How the study uses the data?
The study uses data from the FDA. It is based on ergocalciferol and bromfenac sodium (the active ingredients of Ergocalciferol and Prolensa, respectively), and Ergocalciferol and Prolensa (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Magnesium Orotate and Calcium - 7 seconds ago
- Drug interactions of Magnesium Carbonate and Olanzapine - 11 seconds ago
- Could Lamotrigine cause Pulmonary Artery Stenosis Congenital? - 14 seconds ago
- Could Cordarone cause Blood Sodium Decreased? - 15 seconds ago
- Drug interactions of Hydramine and Emtricitabine - 17 seconds ago
- Could Cutivate cause Gastric Ulcer? - 17 seconds ago
- Could Cimzia cause Death? - 20 seconds ago
- Could Amiodarone Hydrochloride cause Blood Urine Present? - 24 seconds ago
- Drug interactions of Hydramine and Bendeka - 32 seconds ago
- Drug interactions of Macrodantin and Actos - 41 seconds ago